Enveric Biosciences, Inc. (ENVB)
1.42
-0.02
(-1.39%)
USD |
NASDAQ |
Sep 03, 12:49
Enveric Biosciences Research and Development Expense (Annual) : 2.781M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.781M |
| December 31, 2024 | 2.841M |
| December 31, 2023 | 7.252M |
| December 31, 2022 | 8.028M |
| December 31, 2021 | 4.789M |
| December 31, 2020 | 0.1741M |
| December 31, 2019 | 0.00 |
| December 31, 2018 | |
| December 31, 2017 | 0.00 |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 |
| Date | Value |
|---|---|
| December 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.1577M |
| December 31, 2005 | 0.3541M |
| December 31, 2004 | 0.393M |
| December 31, 2003 | 0.4589M |
| December 31, 2002 | 0.4328M |
| December 31, 2001 | 0.6392M |
| December 31, 2000 | 0.5403M |
| December 31, 1999 | 0.3832M |
| December 31, 1998 | 0.7559M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| LENZ Therapeutics, Inc. | 18.67M |
| Impact BioMedical, Inc. | 0.34M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |